1 month ago
On August 10, 2026, Teledyne Technologies Incorporated (NYSE:TDY) agreed to acquire Varex Imaging for $18.90 a share in an all-cash deal valued at about $1.1 billion. It sent Varex Imaging Corporation (NASDAQ:VREX) shares up nearly 50% before the opening bell.
Teledyne is paying a large premium for a smaller X-ray components maker just as Varex posted a genuine earnings beat of its own. Is Teledyne buying real, complementary technology at a fair long-term price, or paying a steep premium right as Varex's turnaround was already starting to work?
CEO Robert Mehrabian said the companies serve similar customers with "uniquely complementary" products and minimal overlap. He noted Teledyne Technologies Incorporated (NYSE:TDY) doesn't make X-ray detectors suited for high-radiation environments like oncology the way Varex does. Both boards unanimously approved the deal, which is expected to close in early 2027.
Nearly a 50% one-day jump in Varex's stock shows the market sees this as a rich price for Teledyne to pay. Integrating Varex's X-ray business, which serves medical, security, and industrial markets, adds real complexity to Teledyne Technologies Incorporated (NYSE:TDY)'s existing operations.
CEO Sunny Sanyal said the deal marks "an exciting new chapter," giving Varex Imaging Corporation (NASDAQ:VREX) access to Teledyne's resources to accelerate use of its imaging technology. Varex also posted third-quarter adjusted profit of 31 cents a share, 10 cents ahead of **** yst estimates, after recovering tariff-related costs and generating $21 million in operating cash flow. It shows the business was already improving before the deal was announced.
#NASDAQ
Teledyne is paying a large premium for a smaller X-ray components maker just as Varex posted a genuine earnings beat of its own. Is Teledyne buying real, complementary technology at a fair long-term price, or paying a steep premium right as Varex's turnaround was already starting to work?
CEO Robert Mehrabian said the companies serve similar customers with "uniquely complementary" products and minimal overlap. He noted Teledyne Technologies Incorporated (NYSE:TDY) doesn't make X-ray detectors suited for high-radiation environments like oncology the way Varex does. Both boards unanimously approved the deal, which is expected to close in early 2027.
Nearly a 50% one-day jump in Varex's stock shows the market sees this as a rich price for Teledyne to pay. Integrating Varex's X-ray business, which serves medical, security, and industrial markets, adds real complexity to Teledyne Technologies Incorporated (NYSE:TDY)'s existing operations.
CEO Sunny Sanyal said the deal marks "an exciting new chapter," giving Varex Imaging Corporation (NASDAQ:VREX) access to Teledyne's resources to accelerate use of its imaging technology. Varex also posted third-quarter adjusted profit of 31 cents a share, 10 cents ahead of **** yst estimates, after recovering tariff-related costs and generating $21 million in operating cash flow. It shows the business was already improving before the deal was announced.
#NASDAQ
2 months ago
Varex Imaging Corporation (NASDAQ:VREX) surged 48.5% to $18.42 on August 10 after Teledyne Technologies Incorporated (NYSE:TDY) agreed to acquire the X-ray technology company for $18.90 per share in cash. The offer represents a 52% premium to Varex's unaffected closing price and values the transaction at approximately $1.1 billion, including equity awards and net debt.
Teledyne shares slipped just 0.15%, suggesting investors did not view the premium as an immediate threat to shareholder value. Varex closed about 2.5% below the offer, representing approximately 2.6% upside to the deal price. The narrow spread shifts the debate from whether Varex Imaging Corporation (NASDAQ:VREX) was undervalued to whether Teledyne Technologies Incorporated (NYSE:TDY) can earn an adequate return.
The strategic fit is visible. Varex Imaging Corporation (NASDAQ:VREX) fills specific gaps in Teledyne's imaging portfolio. Teledyne Technologies Incorporated (NYSE:TDY) has cited anticipated synergies but has not quantified them or disclosed expected EPS accretion or return targets.
Teledyne Technologies Incorporated (NYSE:TDY) is not paying primarily for Varex's current growth rate. It is acquiring technologies and customer relationships that could deepen its position across medical, security, and industrial imaging.
Varex produces X-ray tubes, flat-panel detectors, photon-counting detectors, high-voltage interconnects, and imaging software used by equipment manufacturers. These components support medical diagnostic systems, oncology equipment, cargo inspection, vehicle scanning, and industrial quality control.
#teledyne #NYSE #corporation
Teledyne shares slipped just 0.15%, suggesting investors did not view the premium as an immediate threat to shareholder value. Varex closed about 2.5% below the offer, representing approximately 2.6% upside to the deal price. The narrow spread shifts the debate from whether Varex Imaging Corporation (NASDAQ:VREX) was undervalued to whether Teledyne Technologies Incorporated (NYSE:TDY) can earn an adequate return.
The strategic fit is visible. Varex Imaging Corporation (NASDAQ:VREX) fills specific gaps in Teledyne's imaging portfolio. Teledyne Technologies Incorporated (NYSE:TDY) has cited anticipated synergies but has not quantified them or disclosed expected EPS accretion or return targets.
Teledyne Technologies Incorporated (NYSE:TDY) is not paying primarily for Varex's current growth rate. It is acquiring technologies and customer relationships that could deepen its position across medical, security, and industrial imaging.
Varex produces X-ray tubes, flat-panel detectors, photon-counting detectors, high-voltage interconnects, and imaging software used by equipment manufacturers. These components support medical diagnostic systems, oncology equipment, cargo inspection, vehicle scanning, and industrial quality control.
#teledyne #NYSE #corporation
2 months ago
Varex Imaging (VREX) soared over 48% after Teledyne Technologies (TDY) announced it will acquire the X-Ray company in a deal valued at about $1.1 billion. Teledyne shares edged higher, rising within a buy zone.
Teledyne, part of IBD's aerospace and defense industry group, agreed to pay $18.90 per share in cash, a premium of 52% from Varex's closing price on Friday.
Salt Lake City, Utah-based Varex makes X-ray imaging components and software. Its products are used in medical diagnostic imaging, vehicle inspection systems and other areas.
The acquisition bolsters Teledyne's imaging business. In the second quarter, Teledyne's imaging segment recorded $868.7 million in sales, making it the largest of its four segments and more than half of total revenue.
While the two companies serve similar customers, their products are complementary and share minimal overlap, Teledyne Executive Chairman Robert Mehrabian said in the announcement.
#teledyne #varex #Share #products
Teledyne, part of IBD's aerospace and defense industry group, agreed to pay $18.90 per share in cash, a premium of 52% from Varex's closing price on Friday.
Salt Lake City, Utah-based Varex makes X-ray imaging components and software. Its products are used in medical diagnostic imaging, vehicle inspection systems and other areas.
The acquisition bolsters Teledyne's imaging business. In the second quarter, Teledyne's imaging segment recorded $868.7 million in sales, making it the largest of its four segments and more than half of total revenue.
While the two companies serve similar customers, their products are complementary and share minimal overlap, Teledyne Executive Chairman Robert Mehrabian said in the announcement.
#teledyne #varex #Share #products
